Premium
The novel indole compound SK228 induces apoptosis and FAK/Paxillin disruption in tumor cell lines and inhibits growth of tumor graft in the nude mouse
Author(s) -
Huang SinMing,
Hsu PeiChun,
Chen MeiYu,
Li WenShan,
More Shivaji V.,
Lu KwokTung,
Wang YiChing
Publication year - 2011
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.26401
Subject(s) - apoptosis , paxillin , cell growth , cancer research , biology , cancer cell , survivin , nude mouse , programmed cell death , caspase , microbiology and biotechnology , focal adhesion , signal transduction , cancer , biochemistry , genetics
Drugs in clinical use with indole structure exhibit side effects. Therefore, to search for indole compounds with more efficacy and less side effect for cancer therapy, we developed a novel indole compound SK228 and examined its effects and mechanisms on antitumor growth and invasion inhibition in cell and tumor xenografts in nude mice models. SK228 significantly inhibited growth of different lung and esophageal cancer cell lines at sub‐micromolar range, but not normal lung cells. SK228 induced DNA damages mainly by producing reactive oxygen species (ROS) resulting in apoptosis. SK228 treatment increased the release of cytochrome c into the cytosol along with the increased activity of caspase‐3 and ‐9 without affecting caspase‐8, whereas these effects were attenuated by ROS inhibitor. The expression levels of BCL‐2 family regulators were also affected. Moreover, low‐dose SK228 significantly reduced the invasion of cancer cells. The active phosphorylated form of FAK/Paxillin signaling pathway proteins and active form of RhoA were decreased. Moreover, the F‐actin cytoskeleton was disrupted after low‐dose SK228 treatment. Growth of an A549 tumor cell xenograft was markedly inhibited without significant side effects. SK228‐induced apoptosis was confirmed by terminal deoxynucleotidyl transferase dUTP nick end labeling assay and immunohistochemistry of cleaved caspase‐3 in tumors from treated mice. Our study provides the first evidence that SK228 exhibits cancer cell‐specific cytotoxicity by inducing mitochondria‐mediated apoptosis. In addition, SK228 inhibits cancer cell invasion via FAK/Paxillin disruption at noncytotoxic doses. SK228 can be further tested as a pharmaceutical compound for cancer treatment.